Immunocore Holdings plc (IMCR) ADS EACH REPR ONE ORD SHS

Sell:$29.60Buy:$29.76$0.19 (0.64%)

NASDAQ:0.41%
Market closed | Prices delayed by at least 15 minutes
Sell:$29.60
Buy:$29.76
Change:$0.19 (0.64%)
Market closed | Prices delayed by at least 15 minutes
Sell:$29.60
Buy:$29.76
Change:$0.19 (0.64%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Key people

Bahija Jallal
Chief Executive Officer, Executive Director
Travis Coy
Chief Financial Officer, Executive Vice President, Head of Corporate Development
Tina St Leger
Chief Human Resource Officer
David Berman
Head of Research and Development
John Bell
Independent Chairman of the Board
Ranjeev Krishana
Director
Roy S. Herbst
Non-Executive Independent Director
Siddharth Kaul
Non-Executive Independent Director
Robert Perez
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US45258D1054
  • Market cap
    $1.48bn
  • Employees
    497
  • Shares in issue
    0.00
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.